Literature DB >> 12128010

Receptor-mediated internalization of [3H]-neurotensin in synaptosomal preparations from rat neostriatum.

Ha Minh Ky Nguyen1, Catherine M Cahill, Peter S McPherson, Alain Beaudet.   

Abstract

Following its binding to somatodendritic receptors, the neuropeptide neurotensin (NT) internalizes via a clathrin-mediated process. In the present study, we investigated whether NT also internalizes presynaptically using synaptosomes from rat neostriatum, a region in which NT1 receptors are virtually all presynaptic. Binding of [(3)H]-NT to striatal synaptosomes in the presence of levocabastine to block NT2 receptors is specific, saturable, and has NT1 binding properties. A significant fraction of the bound radioactivity is resistant to hypertonic acid wash indicating that it is internalized. Internalization of [(3)H]-NT, like that of [(125)I]-transferrin, is blocked by sucrose and low temperature, consistent with endocytosis occurring via a clathrin-dependent pathway. However, contrary to what was reported at the somatodendritic level, neither [(3)H]-NT nor [(125)I]-transferrin internalization in synaptosomes is sensitive to the endocytosis inhibitor phenylarsine oxide. Moreover, treatment of synaptosomes with monensin, which prevents internalized receptors from recycling to the plasma membrane, reduces [(3)H]-NT binding and internalization, suggesting that presynaptic NT1 receptors, in contrast to somatodendritic ones, are recycled back to the plasma membrane. Taken together, these results suggest that NT internalizes in nerve terminals via an endocytic pathway that is related to, but is mechanistically distinct from that responsible for NT internalization in nerve cell bodies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12128010     DOI: 10.1016/s0028-3908(02)00054-0

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  4 in total

Review 1.  The role of neurotensin in central nervous system pathophysiology: what is the evidence?

Authors:  Fannie St-Gelais; Claudia Jomphe; Louis-Eric Trudeau
Journal:  J Psychiatry Neurosci       Date:  2006-07       Impact factor: 6.186

2.  Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection.

Authors:  Zeyu Xiao; Etgar Levy-Nissenbaum; Frank Alexis; Andrej Lupták; Benjamin A Teply; Juliana M Chan; Jinjun Shi; Elise Digga; Judy Cheng; Robert Langer; Omid C Farokhzad
Journal:  ACS Nano       Date:  2012-01-03       Impact factor: 15.881

3.  Stress-induced intracellular trafficking of corticotropin-releasing factor receptors in rat locus coeruleus neurons.

Authors:  Beverly A S Reyes; Rita J Valentino; Elisabeth J Van Bockstaele
Journal:  Endocrinology       Date:  2007-10-18       Impact factor: 4.736

4.  Characterization and modulation of the transferrin receptor on brain capillary endothelial cells.

Authors:  Corine C Visser; L Heleen Voorwinden; Daan J A Crommelin; Meindert Danhof; Albertus G de Boer
Journal:  Pharm Res       Date:  2004-05       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.